Production (Stage)
Pharming Group N.V.
PHAR
$11.86
$0.64775.78%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | 191.55% | -192.34% | -1.97% | 78.65% | |
| Total Depreciation and Amortization | 3.70% | -109.27% | 156.76% | -6.40% | |
| Total Amortization of Deferred Charges | -3.62% | -- | -- | 22.78% | |
| Total Other Non-Cash Items | -19.04% | 84.15% | 89.33% | 2.97% | |
| Change in Net Operating Assets | -411.92% | -876.99% | 91.42% | -132.85% | |
| Cash from Operations | -19.40% | -37.42% | 66.44% | 121.15% | |
| Capital Expenditure | 57.24% | 72.24% | 62.79% | 0.33% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -168.04% | 155.24% | -- | -3,734.04% | |
| Cash from Investing | -150.51% | 154.29% | 408.84% | -879.45% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -693.72% | -10,686.25% | 21.19% | 79.37% | |
| Issuance of Common Stock | 727.67% | -- | 27.19% | -78.13% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -157.12% | 101.04% | -15.30% | -2,402.13% | |
| Cash from Financing | -116.08% | -976.61% | 6.05% | -466.91% | |
| Foreign Exchange rate Adjustments | -795.90% | 181.58% | -112.87% | -96.75% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -180.67% | 94.04% | 56.35% | -61.97% | |